Evidence map›Paper›PMID 35286684›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes.

Dominic P Byrne, Mitchell H Omar, Eileen J Kennedy, Patrick A Eyers, John D Scott

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Dominic P ByrneDepartment of Biochemistry and Systems Biology, ISMIB, University of Liverpool, Liverpool, UK.
Mitchell H OmarDepartment of Pharmacology, University of Washington, Seattle, WA, USA.
Eileen J KennedyDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA.
Patrick A EyersDepartment of Biochemistry and Systems Biology, ISMIB, University of Liverpool, Liverpool, UK. patrick.eyers@liverpool.ac.uk.
John D ScottDepartment of Pharmacology, University of Washington, Seattle, WA, USA. scottjdw@uw.edu.
University of Liverpool · GBUniversity of Washington · USUniversity of Georgia · US

Funding

Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Defective PKA Signaling in Cushing's SyndromeR01DK119192 · NIDDK · UNIVERSITY OF WASHINGTON · PI John D Scott · 2018 to 2026
$4.4M
AKAP Modulation of Renal SignalingR01DK119186 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2019 to 2022
$1.5M
Targeting WASF3 to suppress metastasisR01GM134168 · NIGMS · UNIVERSITY OF GEORGIA · PI KENNEDY, EILEEN J · 2019 to 2022
$1.2M
Probing the role of AKAPs in breast cancer using stapled peptide inhibitorsK22CA154600 · NCI · UNIVERSITY OF GEORGIA · PI KENNEDY, EILEEN J · 2011 to 2013
$571k
Molecular mechanisms of PKA mutations underlying Cushing's syndromeF32DK121415 · NIDDK · UNIVERSITY OF WASHINGTON · PI OMAR, MITCHELL HAMED · 2019 to 2021
$205k
Biotechnology and Biological Sciences Research Council BB/N021703/1Biotechnology and Biological Sciences Research Council BB/R000182/1Biotechnology and Biological Sciences Research Council BB/S018514/1NCI NIH HHS K22 CA154600NIDDK NIH HHS F32 DK121415NIDDK NIH HHS R01 DK119186NIDDK NIH HHS R01 DK119192NIDDK NIH HHS T32 DK007247NIGMS NIH HHS R01 GM134168
6 · The paper itself

Abstract

Generation of the prototypic second messenger cAMP instigates numerous signaling events. A major intracellular target of cAMP is Protein kinase A (PKA), a Ser/Thr protein kinase. Where and when this enzyme is activated inside the cell has profound implications on the functional impact of PKA. It is now well established that PKA signaling is focused locally into subcellular signaling "islands" or "signalosomes." The A-Kinase Anchoring Proteins (AKAPs) play a critical role in this process by dictating spatial and temporal aspects of PKA action. Genetically encoded biosensors, small molecule and peptide-based disruptors of PKA signaling are valuable tools for rigorous investigation of local PKA action at the biochemical level. This chapter focuses on approaches to evaluate PKA signaling islands, including a simple assay for monitoring the interaction of an AKAP with a tunable PKA holoenzyme. The latter approach evaluates the composition of PKA holoenzymes, in which regulatory subunits and catalytic subunits can be visualized in the presence of test compounds and small-molecule inhibitors.

Indexed as

A Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesPeptidesSecond Messenger SystemsSignal TransductionA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesPeptidesAKAPcAMPDSFKinase InhibitorMass SpectrometryPeptideProtein kinase A (PKA)SDS-PAGE

Identifiers

PMID35286684
PMCPMC9518671
OpenAlexW4225523372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.